FSHR、ER-α在胃癌组织中的免疫荧光分布及其与GnRHR的共定位观察
Distribution of FSHR and ER-α and Their Colocalization with GnRHR in Gastric Carcinoma
摘要: 目的:研究卵泡刺激素受体(FSHR)和雌激素受体α (ERα)在胃癌组织中的定位、分布及与促性腺激素释放激素受体(GnRHR)共存性。方法:采用免疫荧光化学定位方法。结果:胃癌组织上皮细胞呈FSHR和ERα免疫反应阳性;在胃癌组织中GnRHR免疫反应阳性细胞中观察到了FSHR免疫反应阳性的结果,其中大部分亦呈ERα免疫反应阳性,且分布模式相同;三种免疫反应阳性物质均分布在细胞质内,细胞核呈阴性。结论:GnRHR与FSHR或ERα在胃癌组织分布及其共存性上提示上述相关激素对胃癌的病理发生机制具有重要的影响。
Abstract: Objective: To investigate the distribution of follicle-stimulating hormone receptor (FSHR), estrogen receptorα (ERα) and colocalization with gonadotropin releasing hormone receptor (GnRHR) at the stomach cancer. Methods: Distribution of FSHR and ERα and their colocalization with GnRHR at the stomach cancer were investigated by immune fluorescent chemical registration method. Results: FSHR and ERα immunoreactivities were observed in the cytoplasm of the epithelial cells of stomach cancer respectively with negative nucleus. Conclusion: The colocalization of FSHR or ER-α with GnRHR immunoreactivities was also found in the same structures of two Gastric cancer tissue section. The distribution of gastric cancer tissue and colocalization of FSHR or ERα with GnRHR indicate that they might have an important influence on the stomach cancer pathology change.
文章引用:马玉涛, 石文娜, 李晓林, 周连泉. FSHR、ER-α在胃癌组织中的免疫荧光分布及其与GnRHR的共定位观察[J]. 亚洲肿瘤科病例研究, 2018, 7(3): 33-38. https://doi.org/10.12677/ACRPO.2018.73005

参考文献

[1] Thrumurthy, S.G., Chaudry, M.A., Hochhauser, D., et al. (2013) The Diagnosis and Management of Gastric Cancer. BMJ, 347, 6367-6370. [Google Scholar] [CrossRef] [PubMed]
[2] Van Cutsem, E., Dicato, M., Geva, R., et al. (2011) The Diagnosis and Management of Gastric Cancer: Expert Discussion and Recommendations from the 12th ESMO/World Congress on Gastrointestinal Cancer Barcelona 2010. Annals of Oncology, 22, v1-v9. [Google Scholar] [CrossRef] [PubMed]
[3] Yoon, H. and Kim, N. (2015) Diagnosis and Management of High Risk Group for Gastric Cancer. Gut Liver, 9, 5-17. [Google Scholar] [CrossRef] [PubMed]
[4] 雷媛媛, 马玉涛, 周连泉, 等. 卵泡刺激素及其受体在胃窦癌的表达及免疫荧光定位[J]. 解剖科学进展, 2016, 22(1): 13-15.
[5] 马英东. 雌激素受体α基因rs2234693位点多态性与前列腺癌易感性的meta分析[J]. 中国病理生理杂志, 2015, 31(1): 104-108.
[6] Chen, K.Y., Hsiao, C.F., Chang, G.C., et al. (2015) Estrogen Receptor Gene Polymorphisms and Lung Adenocarcinoma Risk in Never-Smoking Women. Journal of Thoracic Oncology, 10, 1413-1420. [Google Scholar] [CrossRef
[7] Hato, Y., Kondo, N., Yoshimoto, N., et al. (2016) Prognos-tic Impact of a Single-Nucleotide Polymorphism near the CTSO Gene in Hormone Receptor-Positive Breast Cancer Patients. International Journal of Clinical Oncology, 21, 539-547. [Google Scholar] [CrossRef] [PubMed]
[8] Fu, Z., Zhen, H., Zou, F., et al. (2014) Involvement of the Akt Signaling Pathway in ER-α 36 /GRP94-Mediated Signaling in Gastric Cancer. Oncology Letters, 8, 2077-2080. [Google Scholar] [CrossRef] [PubMed]
[9] Qin, J., Liu, M., Ding, Q., et al. (2014) The Direct Effect of Estrogen on Cell Viability and Apoptosis in Human Gastric Cancer Cells. Molecular and Cellular Biochemistry, 395, 99-107. [Google Scholar] [CrossRef] [PubMed]
[10] Kameda, C., Nakamura, M., Tanaka, H., et al. (2010) Oestrogen Receptor-Alpha Contributes to the Regulation of the Hedgehog Signalling Pathway in ERalpha-Positive Gastric Cancer. British Journal of Cancer, 102, 738-747. [Google Scholar] [CrossRef] [PubMed]
[11] Nylander-Koski, O., Kiviluoto, T., Puolakkainen, P., et al. (2007) The Effect of Nitric Oxide, Growth Factors, and Estrogen on Gastric Cell Migration. The Journal of Surgical Research, 143, 230-237.